ArticleOncoTargets and therapy2019

Docosahexaenoic Acid Serving As Sensitizing Agents And Gefitinib Resistance Revertants In EGFR Targeting Treatment.

Xuansheng Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.